DANA HARDESTY: Open Payments
NPI 1962140756 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 12 payments from 7 companies in 2025. Trend: 2023 $210 · 2024 $605 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $204 |
| Pharmacosmos Therapeutics Inc. | 1 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Astellas Pharma Global Development | 1 | $15 |
| GENZYME CORPORATION | 1 | $14 |
Products named: OPDIVO, MONOFERRIC, CREON, KEYTRUDA, Vyloy, KEYTRUDA QLEX, WAYRILZ.
Industry payments across IN — which companies pay providers there.
